Dr. Rebecca A. Sager has been named the inaugural recipient of the Parker Institute for Cancer Immunotherapy’s Endowed Young Investigator Award, recognizing emerging leadership and innovation in oncology research.

The award supports early-career investigators advancing breakthrough research in cancer immunotherapy and related treatment strategies. According to the announcement, Dr. Sager was recognized for her research focused on tumor immunology and the tumor immune microenvironment in clear cell renal cell carcinoma.

The Parker Institute for Cancer Immunotherapy stated that the award was created to encourage promising physician-scientists pursuing innovative approaches in cancer treatment and translational medicine. The recognition also reflects ongoing efforts to support the next generation of oncology researchers working toward personalized therapies and improved patient outcomes.

Dr. Sager will be honored during the American Society of Clinical Oncology (ASCO) Annual Meeting taking place in Chicago.

Source: PR Newswire

Original Release:
https://www.prnewswire.com/news-releases/dr-rebecca-a-sager-named-recipient-of-picis-inaugural-endowed-young-investigator-award-302783240.html